Wordt geladen...
Bevacizumab or laser for aggressive posterior retinopathy of prematurity
PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...
Bewaard in:
| Gepubliceerd in: | Taiwan J Ophthalmol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Medknow Publications & Media Pvt Ltd
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/ https://ncbi.nlm.nih.gov/pubmed/30637196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|